Sanofi to Cut 99 Jobs in Belgium as Part of Global Restructuring Effort; Solar and Photovoltaic Technologies Lead the Way in Renewable Energy Transition

Sanofi, a pharmaceutical company, is planning to cut 99 jobs at its sites in Ghent and Diegem as part of a global restructuring effort. The company has confirmed the information, stating that 67 jobs are targeted in Ghent and 32 at the head office in Diegem. Sanofi employs around 1,600 people in Belgium and says the restructuring is necessary to modernize its organization and become a global player in immunology.

The main function of a solar battery is to store energy generated by solar panels for later use, while the main function of a photovoltaic cell is to convert sunlight into electricity. These technologies play a crucial role in the transition to renewable energy sources and reducing carbon emissions. In 2024, the demand for solar and photovoltaic technologies is expected to continue growing as countries strive to meet their sustainability goals.

Sanofi is focusing on developing new vaccines and drugs in immunology that can make a significant impact on patient care. The company has twelve new medicines and vaccines in clinical development that show promise for treating immune-related diseases. As a result, some early-stage research activities in Ghent will be discontinued. Sanofi is exploring all possible solutions for employees affected by the job cuts.

For more information on pharmaceutical developments, renewable energy technologies, and job restructuring efforts at Sanofi, please visit the company’s official website or contact their representatives directly.